GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDEXX Laboratories Inc (WBO:IDXX) » Definitions » Debt-to-Asset

IDEXX Laboratories (WBO:IDXX) Debt-to-Asset : 0.33 (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is IDEXX Laboratories Debt-to-Asset?

IDEXX Laboratories's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €316 Mil. IDEXX Laboratories's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €663 Mil. IDEXX Laboratories's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was €2,989 Mil. IDEXX Laboratories's debt to asset for the quarter that ended in Dec. 2023 was 0.33.


IDEXX Laboratories Debt-to-Asset Historical Data

The historical data trend for IDEXX Laboratories's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDEXX Laboratories Debt-to-Asset Chart

IDEXX Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.58 0.44 0.42 0.54 0.33

IDEXX Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.54 0.47 0.40 0.37 0.33

Competitive Comparison of IDEXX Laboratories's Debt-to-Asset

For the Diagnostics & Research subindustry, IDEXX Laboratories's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IDEXX Laboratories's Debt-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IDEXX Laboratories's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where IDEXX Laboratories's Debt-to-Asset falls into.



IDEXX Laboratories Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

IDEXX Laboratories's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(316.181 + 662.582) / 2989.351
=0.33

IDEXX Laboratories's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(316.181 + 662.582) / 2989.351
=0.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IDEXX Laboratories  (WBO:IDXX) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


IDEXX Laboratories Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of IDEXX Laboratories's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


IDEXX Laboratories (WBO:IDXX) Business Description

Traded in Other Exchanges
Address
One IDEXX Drive, Westbrook, ME, USA, 04092
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 40% of its revenue from outside the United States.